Exercise Intervention for Chemotherapy-Related Cognitive Dysfunction
A substantial number of cancer survivors who receive chemotherapy report mild to moderate
cognitive impairment following treatment. These impairments have been reported across a
range of cancer types and chemotherapy agents. Adjuvant treatment has been reported to
affect multiple cognitive domains, but three domains appear to be most strongly affected
(i.e., executive functioning, declarative memory, motor function). Exercise participation,
at levels that are readily achievable by most adults (3-5 d/wk, 30-45 min/d), preserves and
enhances cognitive function. Importantly, domains that are enhanced by exercise overlap
substantially with the domains adversely affected by chemotherapy. Accordingly, we propose
a 2 year research program that seeks to develop and test a safe, simple, and effective
exercise intervention to optimize cognitive function following chemotherapy. To begin this
research, we will: 1) conduct a randomized exercise intervention trial among cancer
survivors that report persistent cognitive problems following chemotherapy (exercise, n=30
vs. standard of care, n=30); 2) explore possible mediators and moderators of the
intervention effect on cognition; and 3), conduct a cross-sectional study comparing cancer
survivors enrolled in the trial (n=60) and matched controls (n=40) to evaluate the cognitive
status among survivors in the intervention. We will employ a proven home-based exercise
intervention and state of the art cognitive testing of relevant cognitive domains (e.g.,
Randt Memory Test, Trail Making B, Stroop task, T ask switching, Response compatibility)
that we have used in preliminary studies. We hypothesize that six-months of regular
exercise will enhance cognitive function among cancer survivors, and that cancer survivors
reporting cognitive dysfunction will have lower objectively measured cognitive performance
than adults who have not received chemotherapy. To our knowledge this study would be the
first to examine the influence of regular exercise participation on cognitive function among
cancer survivors that experienced cognitive difficulties following chemotherapy. Completion
of this project will provide our research team with the necessary experience and
intervention effectiveness information that will be used to conduct future more definitive
trials.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Objective measures of cognitive function (a test battery)
6-months
Yes
Charles E. Matthews, PhD
Principal Investigator
Vanderbilt University
United States: Institutional Review Board
tactic
NCT00495703
February 2006
January 2008
Name | Location |
---|---|
Vanderbilt University Medical Center | Nashville, Tennessee 37232-2516 |